Dror Ortho-Design is a pre-revenue medical device company developing ZSmile, a nighttime orthodontic treatment platform designed to straighten teeth while patients sleep. ZSmile is intended as an alternative to traditional clear aligners like Invisalign, which require 20+ hours of daily wear across a series of 20-30 separate aligners over 12-15 months. ZSmile uses pulsating air delivered through a single custom smart aligner to move teeth, targeting patients with crowding and misalignment of the front teeth. ZSmile is a three-component system: a smartphone app for teeth scanning and progress monitoring, a cloud-based AI platform that generates treatment plans and enables remote monitoring by dental professionals, and a hardware smart aligner with a micro-balloon that delivers the pulsating air treatment. The company received FDA 510(k) clearance in February 2026 and holds a European CE Mark. Dror Ortho-Design plans to sell ZSmile through a network of dentists and orthodontists, offer post-treatment monitoring subscriptions, and eventually sell directly to consumers with remote dental oversight. A key part of the distribution strategy targets general practice dentists, who outnumber orthodontists roughly 15 to 1 in the U.S. The company has no commercial agreements with dental professionals and has not yet sold any products. Longer term, Dror Ortho-Design aims to expand its AI-based smartphone imaging technology toward clinical-grade accuracy, which it believes could open opportunities across the broader dental industry.
Read full business overview →Mid to long-term bullish thesis
View →Mid to long-term bearish thesis
View →Mid to long-term bull-bear debate
View → NEWSummary and scoring of the bull-bear debate
View →Find ideas with similar bull or bear theses
View →Investor-relevant company attributes
View →Key risks to the business
View →Comparisons of annual risk disclosures
View →